Putting an end to speculation, Philip Morris International (NYSE: PM) Tuesday confirmed it is in merger talks with rival tobacco company Altria Group (MO). Meanwhile, a statement issued by Altria said it is pursuing a merger deal with Philip Morris. The planned all-stock deal is currently in the discussion stage.
Earlier, there were unconfirmed reports that the companies are planning to become a single entity, which sent Philip Morris’ stock falling during Monday’s trading session. The stock closed the session down about 4%. On the other hand, Altria shares traded sharply higher early Tuesday, after closing the last session higher.
While the merger theory has been doing the rounds for a long time, Altria’s interest in smoke-free cigarette brand iQOS – developed recently by Philip Morris – gives it a new perspective.
Confirming its outperform rating on Philip Morris and reiterating the $102 price target, Wells Fargo in a research note released yesterday attributed the negative stock movement to the Altria deal.
These days, the general market sentiment has not been in favor of Philip Morris, mainly due to lack of transparency in its strategy to move away from conventional cigarettes to smokeless alternatives. Recent studies have found that most of the smoke-free tobacco products are not as safe as they are made out to be.
However, recent data show that Philip Morris’ shift to smokeless products has been well received so far. Last month, the company reported in-line revenues for the second quarter, with the only segment that recorded year-over-growth being Heated Tobacco.
Shares of Philip Morris traded down 6% during Tuesday’s early hours, after closing the previous session lower. Altria was up 8% soon after the session started.
The Kraft Heinz Company (NASDAQ: KHC) reported second-quarter 2021 financial results before the regular market hours on Wednesday. The food company reported Q2 revenue of $6.62 billion, down 0.5% year-over-year
General Motors Co. (NYSE: GM) reported second quarter 2021 earnings results today. Total revenue rose to $34.2 billion from $16.8 billion in the same period last year. GAAP net income
VS Health Corporation (NYSE: CVS) reported second-quarter 2021 earnings results today. Total revenues increased 11.1% to $72.6 billion compared to the same period last year, driven by growth across all